JLL Partners forms a Continuation Fund for Solvias AG

JLL Partners forms a continuation fund aimed at extending its investment in Solvias AG, originally made through an older JLL Partners fund who acquired Solvias in 2020 alongside Water Street Healthcare Partners.

JLL Partners is a middle market private equity firm with over three decades of experience transforming businesses in the healthcare, specialty industrials, and business services sectors. Solvias is an internationally active group headquartered in Switzerland, specializing in contract / pharmaceutical research, testing as well as the manufacturing of pharmaceutical products, offering services like method development, release testing, biological analysis, custom synthesis and ligand / catalyst technologies.

Lenz & Staehelin is assisting JLL Partners and Solvias AG on all Swiss legal aspects of the transaction. The Lenz & Staehelin team is led by partner Floran Ponce (Tax) and includes Maximilien de Ridder and Nicolas Demole (Tax), Roman Graf and Vera Waldburger (Corporate and M&A), David Ledermann, Marcel Tranchet, Manuela Scerri and Alex Coulaud (Financing), Anja Affolter Marino, Julia van Heusden and Daniela Guggenbühl (Employment).